Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial
新辅助纳武利尤单抗联合化疗后序贯反应适应性治疗HPV阳性口咽癌:OPTIMA II期开放标签非随机对照试验
期刊:Jama Oncology
影响因子:
doi:10.1001/jamaoncol.2024.1530
Rosenberg, Ari J; Agrawal, Nishant; Juloori, Aditya; Cursio, John; Gooi, Zhen; Blair, Elizabeth; Chin, Jeffrey; Ginat, Daniel; Pasternak-Wise, Olga; Hasina, Rifat; Starus, Anna; Jones, Frederick S; Izumchenko, Evgeny; MacCracken, Ellen; Wolk, Rachelle; Cipriani, Nicole; Lingen, Mark W; Pearson, Alexander T; Seiwert, Tanguy Y; Haraf, Daniel J; Vokes, Everett E